1. Home
  2. Stocks
  3. Granules Share Price

Granules India Share Price

Pharmaceuticals Mid Cap

₹550.40 +0.45 (0.08%)

05 Nov, 2024 20:50

SIP TrendupStart SIP in GRANULES

Start SIP
Performance Financial Technical Events FnO Shareholding Pattern More FAQ’s

Performance

  • Low
  • ₹539
  • High
  • ₹554
  • 52 Week Low
  • ₹347
  • 52 Week High
  • ₹721
  • Open Price₹550
  • Previous Close₹550
  • Volume1,096,987

Investment Returns

  • Over 1 Month -3.4%
  • Over 3 Month -14.81%
  • Over 6 Month + 30.01%
  • Over 1 Year + 56.43%
SIP Lightning

Smart Investing Starts Here Start SIP with Granules India for Steady Growth!

Granules India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 27.1
  • PEG Ratio
  • 2.1
  • Market Cap Cr
  • 13,340
  • P/B Ratio
  • 4.1
  • Average True Range
  • 23.06
  • EPS
  • 18.1
  • Dividend Yield
  • 0.3
  • MACD Signal
  • -8.86
  • RSI
  • 42.6
  • MFI
  • 35.79

Granules India Financial

IndicatorJun 24Mar 24Dec 23Sep 23Jun 23
Net Sales/Income from operations851.95940.19984.491,009.42821.00
Total Income From Operations851.95940.19984.491,009.42821.00
P/L Before Interest, Excpt. Items & Tax143.38156.30211.39173.66121.94
P/L Before Exceptional Items & Tax125.86136.51191.61156.01107.16
P/L After Tax from Ordinary Activities93.7897.22142.71116.1679.84
Net Profit/Loss For the Period93.7897.22142.71116.1679.84
IndicatorMar 24Mar 23
Revenue From Operations [Gross]3,740.133,915.62
Revenue From Operations [Net]3,740.133,915.62
Total Operating Revenues3,755.093,931.20
Total Revenue3,760.873,941.13
Total Expenses3,169.583,277.19
Profit/Loss Before Tax591.29663.94
Profit/Loss For The Period435.92498.79
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity316.93663.68
Net Cash Used In Investing Activity-302.98-96.45
Net Cash Used in Finance Activity26.14-519.47
Net Inc/Dec In Cash And Equivalent41.3347.50
Cash And Equivalent End Of Year223.08181.75
IndicatorMar 24Mar 23
Total Share Capital24.2424.20
Total Non-Current Liabilities126.13210.04
Total Current Liabilities1,768.551,593.77
Total Capital And Liabilities5,005.634,503.27
Total Non-Current Assets2,371.712,185.30
Total Current Assets2,633.922,317.97
Total Assets5,005.634,503.27
Indicator20242023
EBIT Margin (%)17.6617.87
Return On Capital Employed (%)20.4924.14
Return On Equity (%)14.0118.47
Long Term Debt To Equity (%)1.605.50
Book Value/Share (INR)128.36111.53
IndicatorJun 24Mar 24Dec 23Sep 23Jun 23
Net Sales/Income from operations1,179.871,175.781,155.581,189.49985.52
Total Income From Operations1,179.871,175.781,155.581,189.49985.52
P/L Before Interest, Excpt. Items & Tax208.46204.40198.74161.9887.93
P/L Before Exceptional Items & Tax181.44175.64170.10136.0265.47
P/L After Tax from Ordinary Activities134.65129.65125.65102.1247.90
Net Profit/Loss For the Period134.65129.65125.65102.1247.90
IndicatorMar 24Mar 23
Revenue From Operations [Gross]4,506.374,496.34
Revenue From Operations [Net]4,506.374,496.34
Total Operating Revenues4,506.374,511.92
Total Revenue4,510.774,525.70
Total Expenses3,963.543,838.52
Profit/Loss Before Tax547.23687.17
Profit/Loss For The Period405.31516.60
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity439.41738.75
Net Cash Used In Investing Activity-360.16-191.36
Net Cash Used in Finance Activity7.66-440.29
Net Inc/Dec In Cash And Equivalent89.54106.84
Cash And Equivalent End Of Year381.10291.56
IndicatorMar 24Mar 23
Total Share Capital24.2424.20
Total Non-Current Liabilities213.15256.15
Total Current Liabilities2,082.291,813.50
Total Capital And Liabilities5,520.984,904.56
Total Non-Current Assets2,615.932,330.42
Total Current Assets2,905.052,574.15
Total Assets5,520.984,904.56
Indicator20242023
EBIT Margin (%)14.4916.46
Return On Capital Employed (%)18.9924.04
Return On Equity (%)12.5618.22
Long Term Debt To Equity (%)2.135.24
Book Value/Share (INR)133.08117.13

Granules India Technicals

EMA & SMA

Current Price
₹550.40
+ 0.45 (0.08%)
pointer
  • stock-down_img
  • Bullish Moving Average 3
  • stock-up_img
  • Bearish Moving Average 13
  • 20 Day
  • ₹567.49
  • 50 Day
  • ₹579.44
  • 100 Day
  • ₹564.31
  • 200 Day
  • ₹516.95

Resistance and Support

547.85 Pivot Speed
  • R3 572.15
  • R2 563.20
  • R1 556.80
  • S1 541.45
  • S2 532.50
  • S3 526.10

Is Granules India Worth Buying?

BUY SELL HOLD

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Granules India Ltd. is a pharmaceutical company specializing in the production of Active Pharmaceutical Ingredients (APIs), pharmaceutical formulations, and over-the-counter (OTC) products. It operates globally, supplying high-quality, cost-effective solutions to customers in over 60 countries. Granules India has an operating revenue of Rs. 4,700.72 Cr. on a trailing 12-month basis. An annual revenue de-growth of 0% needs improvement, Pre-tax margin of 12% is healthy, ROE of 12% is good. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 13% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 81 which is a GOOD score indicating consistency in earnings, a RS Rating of 54 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 35 indicates it belongs to a strong industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Granules India Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-06 Quarterly Results
2024-07-30 Quarterly Results
2024-05-15 Audited Results & Final Dividend
2024-01-23 Quarterly Results
2023-11-09 Quarterly Results
Date Purpose Remarks
2023-08-03 FINAL Rs.1.50 per share(150%)Final Dividend
2022-02-18 INTERIM Re.0.25 per share (25%) Third Interim Dividend
2021-11-25 INTERIM Re.0.25 per share (25%) Second Interim Dividend
2021-08-06 INTERIM Rs.0.25 per share(25%)First Interim Dividend
2021-02-09 INTERIM Rs.0.25 per share (25%) Third Interim Dividend

Granules India F&O

Granules India Shareholding Pattern

38.87%
7.86%
6.12%
19.49%
18.29%
9.37%
  • NSE Symbol
  • GRANULES
  • BSE Symbol
  • 532482
  • Chairman & Managing Director
  • Dr. Krishna Prasad Chigurupati
  • ISIN
  • INE101D01020

Granules India FAQs

Granules India share price is ₹550 As on 05 November, 2024 | 20:36

The Market Cap of Granules India is ₹13340 Cr As on 05 November, 2024 | 20:36

The P/E ratio of Granules India is 27.1 As on 05 November, 2024 | 20:36

The PB ratio of Granules India is 4.1 As on 05 November, 2024 | 20:36

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

The Vigilance Awareness Week for the year 2024 (VAW 2024) would be observed from October 28, 2024 to November 03, 2024
“सत्यनिष्ठा की संस्कृनि सेराष्र की समद्ृधि” “Culture of Integrity for Nation's Prosperity”
e-pledge link (https://pledge.cvc.nic.in/)

5paisa Capital Ltd. CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

*Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

Contact Us

Attention Investors

  • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
  • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
  • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Email: support@5paisa.com

Support Desk Helpline: 8976689766

©2024, 5paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.